(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 3.78% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Elanco Animal Health's revenue in 2024 is $4,417,000,000.On average, 6 Wall Street analysts forecast ELAN's revenue for 2024 to be $2,213,541,337,942, with the lowest ELAN revenue forecast at $2,197,660,309,038, and the highest ELAN revenue forecast at $2,224,241,252,031. On average, 6 Wall Street analysts forecast ELAN's revenue for 2025 to be $2,313,628,546,306, with the lowest ELAN revenue forecast at $2,283,930,060,963, and the highest ELAN revenue forecast at $2,345,058,342,327.
In 2026, ELAN is forecast to generate $2,439,963,449,935 in revenue, with the lowest revenue forecast at $2,430,376,662,131 and the highest revenue forecast at $2,444,145,314,538.